Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia

Ceftaroline is a new parenteral cephalosporin approved by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) for the treatment of complicated skin and soft tissue infections (cSSTIs) including those due to methicillin-resistant Staphylococcus aureus (MRSA), and communi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mpenge, Mbiye A, MacGowan, Alasdair P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396454/
https://www.ncbi.nlm.nih.gov/pubmed/25897241
http://dx.doi.org/10.2147/TCRM.S75412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396454/
https://www.ncbi.nlm.nih.gov/pubmed/25897241
http://dx.doi.org/10.2147/TCRM.S75412

Ejemplares similares